The North American market for capsule and surgical endoscopes is expected to grow at a compound annual growth rate of 13.8 percent from 2013 to 2018.
The combined U.S. and European market for gastrointestinal endoscopy is expected to reach a value of more than $4.4 billion by 2020, according to an iData Research report.
The market for colorectal cancer therapies will hold steady, valued at $7.7 billion by 2023, according to a Decision Resources Group news release.
The global endoscopy market is projected to reach $43 billion by 2019, according to a report from Research and Markets.
The Asia Pacific gastrointestinal endoscopy device market will grow quickly through 2023, at a 9 percent compound annual growth rate, according to a new report from Decision Resources Group.
More articles on gastroenterology:
How to keep up with meaningful use requirements in GI
Roswell Park Cancer Institute opens endoscopy center
American Journal of Medicine launches HCV resource
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
